224 related articles for article (PubMed ID: 28365779)
21. Neural induction of porcine-induced pluripotent stem cells and further differentiation using glioblastoma-cultured medium.
Kim E; Kim M; Hwang SU; Kim J; Lee G; Park YS; Hyun SH
J Cell Mol Med; 2019 Mar; 23(3):2052-2063. PubMed ID: 30609263
[TBL] [Abstract][Full Text] [Related]
22. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
23. The application of human pluripotent stem cells to model the neuronal and glial components of neurodevelopmental disorders.
Lee KM; Hawi ZH; Parkington HC; Parish CL; Kumar PV; Polo JM; Bellgrove MA; Tong J
Mol Psychiatry; 2020 Feb; 25(2):368-378. PubMed ID: 31455859
[TBL] [Abstract][Full Text] [Related]
24. Cellular Phenotypes in Human iPSC-Derived Neurons from a Genetic Model of Autism Spectrum Disorder.
Deshpande A; Yadav S; Dao DQ; Wu ZY; Hokanson KC; Cahill MK; Wiita AP; Jan YN; Ullian EM; Weiss LA
Cell Rep; 2017 Dec; 21(10):2678-2687. PubMed ID: 29212016
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9-mediated Knockout of the Neuropsychiatric Risk Gene KCTD13 Causes Developmental Deficits in Human Cortical Neurons Derived from Induced Pluripotent Stem Cells.
Kizner V; Naujock M; Fischer S; Jäger S; Reich S; Schlotthauer I; Zuckschwerdt K; Geiger T; Hildebrandt T; Lawless N; Macartney T; Dorner-Ciossek C; Gillardon F
Mol Neurobiol; 2020 Feb; 57(2):616-634. PubMed ID: 31402430
[TBL] [Abstract][Full Text] [Related]
26. A molecular model for neurodevelopmental disorders.
Gigek CO; Chen ES; Ota VK; Maussion G; Peng H; Vaillancourt K; Diallo AB; Lopez JP; Crapper L; Vasuta C; Chen GG; Ernst C
Transl Psychiatry; 2015 May; 5(5):e565. PubMed ID: 25966365
[TBL] [Abstract][Full Text] [Related]
27. Differentiation of Human Induced Pluripotent Stem Cells into Cortical Neurons to Advance Precision Medicine.
Silva MC; Nandi G; Haggarty SJ
Methods Mol Biol; 2022; 2429():143-174. PubMed ID: 35507160
[TBL] [Abstract][Full Text] [Related]
28. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
Wen Z
J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
[TBL] [Abstract][Full Text] [Related]
29. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.
Nestor MW; Phillips AW; Artimovich E; Nestor JE; Hussman JP; Blatt GJ
Autism Res; 2016 May; 9(5):513-35. PubMed ID: 26426199
[TBL] [Abstract][Full Text] [Related]
30. Modeling neurodevelopmental disorders using human neurons.
Chailangkarn T; Acab A; Muotri AR
Curr Opin Neurobiol; 2012 Oct; 22(5):785-90. PubMed ID: 22717528
[TBL] [Abstract][Full Text] [Related]
31. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
[TBL] [Abstract][Full Text] [Related]
32. Aberrant calcium channel splicing drives defects in cortical differentiation in Timothy syndrome.
Panagiotakos G; Haveles C; Arjun A; Petrova R; Rana A; Portmann T; Paşca SP; Palmer TD; Dolmetsch RE
Elife; 2019 Dec; 8():. PubMed ID: 31868578
[TBL] [Abstract][Full Text] [Related]
33. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
34. Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments.
Zhang X; Li Z; Liu Y; Gai Z
Int J Med Sci; 2021; 18(2):459-473. PubMed ID: 33390815
[TBL] [Abstract][Full Text] [Related]
35. Chromatin Interaction Changes during the iPSC-NPC Model to Facilitate the Study of Biologically Significant Genes Involved in Differentiation.
Choi WY; Hwang JH; Lee JY; Cho AN; Lee AJ; Jung I; Cho SW; Kim LK; Kim YJ
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33050006
[TBL] [Abstract][Full Text] [Related]
36. Pathological priming causes developmental gene network heterochronicity in autistic subject-derived neurons.
Schafer ST; Paquola ACM; Stern S; Gosselin D; Ku M; Pena M; Kuret TJM; Liyanage M; Mansour AA; Jaeger BN; Marchetto MC; Glass CK; Mertens J; Gage FH
Nat Neurosci; 2019 Feb; 22(2):243-255. PubMed ID: 30617258
[TBL] [Abstract][Full Text] [Related]
37. The use of iPSC technology for modeling Autism Spectrum Disorders.
Russo FB; Brito A; de Freitas AM; Castanha A; de Freitas BC; Beltrão-Braga PCB
Neurobiol Dis; 2019 Oct; 130():104483. PubMed ID: 31129084
[TBL] [Abstract][Full Text] [Related]
38. Modeling developmental neuropsychiatric disorders with iPSC technology: challenges and opportunities.
Young-Pearse TL; Morrow EM
Curr Opin Neurobiol; 2016 Feb; 36():66-73. PubMed ID: 26517284
[TBL] [Abstract][Full Text] [Related]
39. Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons.
Trilck M; Peter F; Zheng C; Frank M; Dobrenis K; Mascher H; Rolfs A; Frech MJ
Brain Res; 2017 Feb; 1657():52-61. PubMed ID: 27923633
[TBL] [Abstract][Full Text] [Related]
40. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities.
Madison JM; Zhou F; Nigam A; Hussain A; Barker DD; Nehme R; van der Ven K; Hsu J; Wolf P; Fleishman M; O'Dushlaine C; Rose S; Chambert K; Lau FH; Ahfeldt T; Rueckert EH; Sheridan SD; Fass DM; Nemesh J; Mullen TE; Daheron L; McCarroll S; Sklar P; Perlis RH; Haggarty SJ
Mol Psychiatry; 2015 Jun; 20(6):703-17. PubMed ID: 25733313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
